author_facet Billaud, M
Busson, P
Huang, D
Mueller-Lantzch, N
Rousselet, G
Pavlish, O
Wakasugi, H
Seigneurin, J M
Tursz, T
Lenoir, G M
Billaud, M
Busson, P
Huang, D
Mueller-Lantzch, N
Rousselet, G
Pavlish, O
Wakasugi, H
Seigneurin, J M
Tursz, T
Lenoir, G M
author Billaud, M
Busson, P
Huang, D
Mueller-Lantzch, N
Rousselet, G
Pavlish, O
Wakasugi, H
Seigneurin, J M
Tursz, T
Lenoir, G M
spellingShingle Billaud, M
Busson, P
Huang, D
Mueller-Lantzch, N
Rousselet, G
Pavlish, O
Wakasugi, H
Seigneurin, J M
Tursz, T
Lenoir, G M
Journal of Virology
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
Virology
Insect Science
Immunology
Microbiology
author_sort billaud, m
spelling Billaud, M Busson, P Huang, D Mueller-Lantzch, N Rousselet, G Pavlish, O Wakasugi, H Seigneurin, J M Tursz, T Lenoir, G M 0022-538X 1098-5514 American Society for Microbiology Virology Insect Science Immunology Microbiology http://dx.doi.org/10.1128/jvi.63.10.4121-4128.1989 <jats:p>Anaplastic nasopharyngeal carcinoma (NPC) cells invariably harbor the Epstein-Barr virus (EBV) genome, an association that is unique among human virus-associated cancers. Although EBV is able to replicate in epithelial cells, results with expression of the EBV receptor (complement receptor type 2 [CR2]; also called CD21) in normal and malignant epithelial cells are conflicting. We grew five different EBV-associated NPC tumors in nude mice, and by using a sensitive transcriptional assay, we detected a very weak transcription signal of the EBV receptor CR2 gene in these cells. This suggests that low levels of EBV receptor may be expressed by malignant epithelial nasopharyngeal cells. The gene coding for Blast2/CD23, a B-cell activation molecule induced by EBV, was transcribed in three of the transplanted NPC tumors. The soluble form of the Blast2/CD23 protein was also detected in medium taken from short-term cultures of the same NPC cell lines. In contrast to the lymphoid system, in which Blast2/CD23 expression is associated with EBV nuclear antigen (EBNA2) expression, no EBNA2 protein could be detected in these NPC epithelial cells. Our study represents the first demonstration of Blast2/CD23 expression in epithelial cells. As the soluble form of the Blast2/CD23 protein possesses growth factor activity associated with EBV-induced B-cell immortalization, these results suggest a possible role for this molecule in the pathogenesis of NPC.</jats:p> Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2 Journal of Virology
doi_str_mv 10.1128/jvi.63.10.4121-4128.1989
facet_avail Online
Free
finc_class_facet Medizin
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qdmkuNjMuMTAuNDEyMS00MTI4LjE5ODk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qdmkuNjMuMTAuNDEyMS00MTI4LjE5ODk
institution DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
imprint American Society for Microbiology, 1989
imprint_str_mv American Society for Microbiology, 1989
issn 0022-538X
1098-5514
issn_str_mv 0022-538X
1098-5514
language English
mega_collection American Society for Microbiology (CrossRef)
match_str billaud1989epsteinbarrvirusebvcontainingnasopharyngealcarcinomacellsexpressthebcellactivationantigenblast2cd23andlowlevelsoftheebvreceptorcr2
publishDateSort 1989
publisher American Society for Microbiology
recordtype ai
record_format ai
series Journal of Virology
source_id 49
title Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_unstemmed Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_full Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_fullStr Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_full_unstemmed Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_short Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_sort epstein-barr virus (ebv)-containing nasopharyngeal carcinoma cells express the b-cell activation antigen blast2/cd23 and low levels of the ebv receptor cr2
topic Virology
Insect Science
Immunology
Microbiology
url http://dx.doi.org/10.1128/jvi.63.10.4121-4128.1989
publishDate 1989
physical 4121-4128
description <jats:p>Anaplastic nasopharyngeal carcinoma (NPC) cells invariably harbor the Epstein-Barr virus (EBV) genome, an association that is unique among human virus-associated cancers. Although EBV is able to replicate in epithelial cells, results with expression of the EBV receptor (complement receptor type 2 [CR2]; also called CD21) in normal and malignant epithelial cells are conflicting. We grew five different EBV-associated NPC tumors in nude mice, and by using a sensitive transcriptional assay, we detected a very weak transcription signal of the EBV receptor CR2 gene in these cells. This suggests that low levels of EBV receptor may be expressed by malignant epithelial nasopharyngeal cells. The gene coding for Blast2/CD23, a B-cell activation molecule induced by EBV, was transcribed in three of the transplanted NPC tumors. The soluble form of the Blast2/CD23 protein was also detected in medium taken from short-term cultures of the same NPC cell lines. In contrast to the lymphoid system, in which Blast2/CD23 expression is associated with EBV nuclear antigen (EBNA2) expression, no EBNA2 protein could be detected in these NPC epithelial cells. Our study represents the first demonstration of Blast2/CD23 expression in epithelial cells. As the soluble form of the Blast2/CD23 protein possesses growth factor activity associated with EBV-induced B-cell immortalization, these results suggest a possible role for this molecule in the pathogenesis of NPC.</jats:p>
container_issue 10
container_start_page 4121
container_title Journal of Virology
container_volume 63
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339188323975168
geogr_code not assigned
last_indexed 2024-03-01T15:44:06.745Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Epstein-Barr+virus+%28EBV%29-containing+nasopharyngeal+carcinoma+cells+express+the+B-cell+activation+antigen+blast2%2FCD23+and+low+levels+of+the+EBV+receptor+CR2&rft.date=1989-10-01&genre=article&issn=1098-5514&volume=63&issue=10&spage=4121&epage=4128&pages=4121-4128&jtitle=Journal+of+Virology&atitle=Epstein-Barr+virus+%28EBV%29-containing+nasopharyngeal+carcinoma+cells+express+the+B-cell+activation+antigen+blast2%2FCD23+and+low+levels+of+the+EBV+receptor+CR2&aulast=Lenoir&aufirst=G+M&rft_id=info%3Adoi%2F10.1128%2Fjvi.63.10.4121-4128.1989&rft.language%5B0%5D=eng
SOLR
_version_ 1792339188323975168
author Billaud, M, Busson, P, Huang, D, Mueller-Lantzch, N, Rousselet, G, Pavlish, O, Wakasugi, H, Seigneurin, J M, Tursz, T, Lenoir, G M
author_facet Billaud, M, Busson, P, Huang, D, Mueller-Lantzch, N, Rousselet, G, Pavlish, O, Wakasugi, H, Seigneurin, J M, Tursz, T, Lenoir, G M, Billaud, M, Busson, P, Huang, D, Mueller-Lantzch, N, Rousselet, G, Pavlish, O, Wakasugi, H, Seigneurin, J M, Tursz, T, Lenoir, G M
author_sort billaud, m
container_issue 10
container_start_page 4121
container_title Journal of Virology
container_volume 63
description <jats:p>Anaplastic nasopharyngeal carcinoma (NPC) cells invariably harbor the Epstein-Barr virus (EBV) genome, an association that is unique among human virus-associated cancers. Although EBV is able to replicate in epithelial cells, results with expression of the EBV receptor (complement receptor type 2 [CR2]; also called CD21) in normal and malignant epithelial cells are conflicting. We grew five different EBV-associated NPC tumors in nude mice, and by using a sensitive transcriptional assay, we detected a very weak transcription signal of the EBV receptor CR2 gene in these cells. This suggests that low levels of EBV receptor may be expressed by malignant epithelial nasopharyngeal cells. The gene coding for Blast2/CD23, a B-cell activation molecule induced by EBV, was transcribed in three of the transplanted NPC tumors. The soluble form of the Blast2/CD23 protein was also detected in medium taken from short-term cultures of the same NPC cell lines. In contrast to the lymphoid system, in which Blast2/CD23 expression is associated with EBV nuclear antigen (EBNA2) expression, no EBNA2 protein could be detected in these NPC epithelial cells. Our study represents the first demonstration of Blast2/CD23 expression in epithelial cells. As the soluble form of the Blast2/CD23 protein possesses growth factor activity associated with EBV-induced B-cell immortalization, these results suggest a possible role for this molecule in the pathogenesis of NPC.</jats:p>
doi_str_mv 10.1128/jvi.63.10.4121-4128.1989
facet_avail Online, Free
finc_class_facet Medizin, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qdmkuNjMuMTAuNDEyMS00MTI4LjE5ODk
imprint American Society for Microbiology, 1989
imprint_str_mv American Society for Microbiology, 1989
institution DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3
issn 0022-538X, 1098-5514
issn_str_mv 0022-538X, 1098-5514
language English
last_indexed 2024-03-01T15:44:06.745Z
match_str billaud1989epsteinbarrvirusebvcontainingnasopharyngealcarcinomacellsexpressthebcellactivationantigenblast2cd23andlowlevelsoftheebvreceptorcr2
mega_collection American Society for Microbiology (CrossRef)
physical 4121-4128
publishDate 1989
publishDateSort 1989
publisher American Society for Microbiology
record_format ai
recordtype ai
series Journal of Virology
source_id 49
spelling Billaud, M Busson, P Huang, D Mueller-Lantzch, N Rousselet, G Pavlish, O Wakasugi, H Seigneurin, J M Tursz, T Lenoir, G M 0022-538X 1098-5514 American Society for Microbiology Virology Insect Science Immunology Microbiology http://dx.doi.org/10.1128/jvi.63.10.4121-4128.1989 <jats:p>Anaplastic nasopharyngeal carcinoma (NPC) cells invariably harbor the Epstein-Barr virus (EBV) genome, an association that is unique among human virus-associated cancers. Although EBV is able to replicate in epithelial cells, results with expression of the EBV receptor (complement receptor type 2 [CR2]; also called CD21) in normal and malignant epithelial cells are conflicting. We grew five different EBV-associated NPC tumors in nude mice, and by using a sensitive transcriptional assay, we detected a very weak transcription signal of the EBV receptor CR2 gene in these cells. This suggests that low levels of EBV receptor may be expressed by malignant epithelial nasopharyngeal cells. The gene coding for Blast2/CD23, a B-cell activation molecule induced by EBV, was transcribed in three of the transplanted NPC tumors. The soluble form of the Blast2/CD23 protein was also detected in medium taken from short-term cultures of the same NPC cell lines. In contrast to the lymphoid system, in which Blast2/CD23 expression is associated with EBV nuclear antigen (EBNA2) expression, no EBNA2 protein could be detected in these NPC epithelial cells. Our study represents the first demonstration of Blast2/CD23 expression in epithelial cells. As the soluble form of the Blast2/CD23 protein possesses growth factor activity associated with EBV-induced B-cell immortalization, these results suggest a possible role for this molecule in the pathogenesis of NPC.</jats:p> Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2 Journal of Virology
spellingShingle Billaud, M, Busson, P, Huang, D, Mueller-Lantzch, N, Rousselet, G, Pavlish, O, Wakasugi, H, Seigneurin, J M, Tursz, T, Lenoir, G M, Journal of Virology, Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2, Virology, Insect Science, Immunology, Microbiology
title Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_full Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_fullStr Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_full_unstemmed Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_short Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
title_sort epstein-barr virus (ebv)-containing nasopharyngeal carcinoma cells express the b-cell activation antigen blast2/cd23 and low levels of the ebv receptor cr2
title_unstemmed Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
topic Virology, Insect Science, Immunology, Microbiology
url http://dx.doi.org/10.1128/jvi.63.10.4121-4128.1989